PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17240363-4	2007	We hypothesized that depsipeptide would modulate MMP-2 and MMP-9 production in lung adenocarcinoma cells line (A549).	Depsipeptides	21-33	matrix metallopeptidase 2	Homo sapiens	49-54	
17240363-7	2007	RESULTS: The results showed that depsipeptide treatment decreased the expressions of MMP-2 and MMP-9 in dose-dependent manner.	Depsipeptides	33-45	matrix metallopeptidase 2	Homo sapiens	85-90	
17240363-9	2007	Further immunocytochemistry studies showed the weak expression of MMP-2 and MMP-9 in depsipeptide treated cells.	Depsipeptides	85-97	matrix metallopeptidase 2	Homo sapiens	66-71	
17240363-10	2007	CONCLUSION: We speculate that inhibition of metastasis-specific MMPs in cancer cells may be one of the targets for anticancer function of depsipeptide, and thus provides the molecular basis for the development of depsipeptide as a novel chemopreventive agent for metastatic lung cancer.	Depsipeptides	138-150	matrix metallopeptidase 2	Homo sapiens	64-68	
17240363-10	2007	CONCLUSION: We speculate that inhibition of metastasis-specific MMPs in cancer cells may be one of the targets for anticancer function of depsipeptide, and thus provides the molecular basis for the development of depsipeptide as a novel chemopreventive agent for metastatic lung cancer.	Depsipeptides	213-225	matrix metallopeptidase 2	Homo sapiens	64-68